(InformingNews.com) – Sometimes, there’s so much happening in the news, it is easy to miss an important story, especially when it involves the various actions occurring within the federal government. A recent story about the FDA loosening abortion restrictions may not have caught the media’s eye, but it is concerning for pro-life advocates.
In a December 16 decision, the US Food and Drug Administration (FDA) announced it would allow for the shipment by mail of the abortion pill mifepristone. Due to the COVID-19 pandemic, the Biden administration had suspended the previous FDA requirement that required patients to pick up this medication in person. The ruling by the FDA now makes the suspension permanent.
President of the pro-life group Students for Life, Kristen Hawkins, spoke out about the FDA’s decision, labeling it as careless.
— Global News Report (@robinsnewswire) December 17, 2021
Doctors prescribe mifepristone along with misoprostol to terminate pregnancies up to 70 days in gestation. Hawkins explained using the drug combination puts women at a higher risk for complications than surgical abortion and requires complete doctor supervision. By allowing drug sales through the mail, the FDA and the Biden administration are showing complete disregard for the safety of women.
The FDA ruling will not have an impact in states that have laws banning abortion pill delivery by mail or where legislation limits access to such medications.
Copyright 2021, InformingNews.com